News & Updates

Michael Abramoff

Dr. Michael Abramoff, MD, PhD is the Founder and Executive Chairman of IDx, the Autonomous AI diagnostics company which was the first in any field of medicine to get FDA approval for an autonomous AI. In primary care, it can instantaneously, at the point of care, diagnoses diabetic retinopathy and diabetic macular edema. Dr Abramoff developed an ethical foundation for autonomous AI that was used during the design, validation, and regulatory and payment pathways for autonomous AI. As a Professor of Ophthalmology at the University of Iowa, Dr. Abramoff continues to see patients and has mentored dozens of graduate students, ophthalmology residents, and retina fellows. His passion is to use AI to improve the affordability, accessibility and quality of care.

This website uses cookies to ensure you get the best experience.